TY - CONF T1 - Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial JO - SKIN The Journal of Cutaneous Medicine PY - 2022/03/04 AU - Paller A AU - Blauvelt A AU - Soong W AU - Imafuku S AU - Hong C-H AU - Schuttelaar M AU - Amoudruz P AU - Kurbasic A AU - Soldbro L AU - Lophaven K AU - Cork M et al ED - DO - DOI: 10.25251/skin.6.supp.s29 PB - National Society for Cutaneous Medicine VL - 6 IS - 2 SP - s29 EP - s29 Y2 - 2025/07/27 ER -